Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Chemotactic signaling and beyond: link between interleukin-16 and axonal degeneration in multiple sclerosis.
Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.
Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed.
Chronic inflammatory demyelinating polyneuropathy associated with alopecia totalis and Sjögren syndrome.
Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis.
How Does Transcranial Magnetic Stimulation Influence Glial Cells in the Central Nervous System?
Structural correlates for fatigue in early relapsing remitting multiple sclerosis.
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.
Homeostasis of Microglia in the Adult Brain: Review of Novel Microglia Depletion Systems.
Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood-brain barrier permeability in middle-aged mice.
Transplantation of mesenchymal stem cells in a laryngeal carcinoma patient with radiation myelitis.
Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.
Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE.
Acute demyelinating events following vaccines - a case centered analysis.
Decreased NAA in Gray Matter is Correlated with Decreased Availability of Acetate in White Matter in Postmortem Multiple Sclerosis Cortex.
Lotensin: Cheap 180
Hypothalamic abnormality in patients with inflammatory demyelinating disorders.
Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms.
Hypothesis: Fingolimod explores new horizons in treatment of lymphoma.
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4.
Demonstration of equivalence of a generic glatiramer acetate (Glatopa™).
Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes.
Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup.
Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors.
Pages
« first
‹ previous
…
711
712
713
714
715
716
717
718
719
…
next ›
last »